3.69
+0(+0.00%)
Currency In USD
| Previous Close | 3.69 |
| Open | 3.83 |
| Day High | 3.83 |
| Day Low | 3.64 |
| 52-Week High | 7.03 |
| 52-Week Low | 2.03 |
| Volume | 66,669 |
| Average Volume | 133,911 |
| Market Cap | 193.24M |
| PE | -3.84 |
| EPS | -0.96 |
| Moving Average 50 Days | 3.81 |
| Moving Average 200 Days | 3.35 |
| Change | 0 |
If you invested $1000 in Sight Sciences, Inc. (SGHT) since IPO date, it would be worth $110.15 as of September 09, 2025 at a share price of $3.69. Whereas If you bought $1000 worth of Sight Sciences, Inc. (SGHT) shares 3 years ago, it would be worth $495.3 as of September 09, 2025 at a share price of $3.69.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Sight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare’s® Expanded Coverage of Glaucoma Surgical Treatments
GlobeNewswire Inc.
51 minutes ago
UnitedHealthcare’s Coverage Policy includes procedures enabled with OMNI Surgical System technology, the leader in implant-free MIGS, are proven and medically necessaryMENLO PARK, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nas
Sight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO
GlobeNewswire Inc.
Sep 02, 2025 8:05 PM GMT
This report provides an evidence-based review of current treatments for managing dry eye disease (DED) and highlights support for TearCare based on strong clinical dataMENLO PARK, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nas
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference
GlobeNewswire Inc.
Aug 26, 2025 8:05 PM GMT
MENLO PARK, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company) an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to tr